Fall 2024
Battle for Women’s Global Health
In the 1980s, an outbreak of Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) spread across the United States. Roughly 20% of the population of gay men in the U.S. contracted HIV in the early 1980s, with some cities seeing almost 50% of the gay population affected.1 Within the same period, the prevalence of HIV among women rose to 12%.2 The rise of infectious diseases in minority populations highlighted the need for medical attention in a global context.
Spring 2025
Revolutionizing Resuscitation: Triiodothyronine Nanoparticles for Cardiac Arrest
According to the CDC, more than 356,000 people have an out-of-hospital cardiac arrest in the United States every year. 60% to 80% of these patients die before reaching the hospital. For half a century, a 1mg dose of epinephrine (EPI), administered once every 3-5 minutes, has been the medication protocol for advanced life support in cardiac arrest. This is an old protocol, first implemented in Advanced Cardiac Life Support (ACLS) guidelines in 1974 and was based on research from 1905. Across numerous studies, reviews, and publications in resuscitation science, researchers have uncovered the shortcomings of this drug in cardiac arrest management including poor neurologic function and long-term mortality outcomes.
Fall 2025
Explainable AI: Improving Algorithmic Standards in Patient Care
Since October 3, 2024, the FDA has approved 950 medical devices powered by artificial intelligence (AI). 478 of those — more than half — were approved in just the last four years. AI is reshaping medicine, from diagnostics and drug discovery to patient care management. Understanding how AI makes decisions is paramount in a landscape of increasingly complex algorithms.
Read more.